Calretin Immunohistochemistry at Test Zone Diagnostic Center

Calretin Immunohistochemistry at Test Zone Diagnostic Center

Calretin Immunohistochemistry at Test Zone Diagnostic Center is a highly specialized, state-of-the-art histopathological analysis utilized to detect the presence of calretinin, a 29 kDa calcium-binding protein belonging to the EF-hand family. This protein is encoded by the CALB2 gene and is primarily expressed in specific central and peripheral nervous system neurons, mesothelial cells, steroid-producing cells of the adrenal cortex, and certain ovarian and testicular structures. In clinical pathology, Calretin Immunohistochemistry serves as an indispensable diagnostic tool, offering exceptional sensitivity and specificity in differentiating various benign and malignant neoplasms, as well as identifying congenital neurodevelopmental disorders of the gastrointestinal tract.

The process of immunohistochemistry (IHC) combines anatomical, immunological, and biochemical techniques to image specific tissue antigens. When a tissue biopsy is submitted to Test Zone Diagnostic Center in Peshawar, Pakistan, thin sections are prepared from the formalin-fixed paraffin-embedded (FFPE) tissue block. These sections are then incubated with highly specific monoclonal or polyclonal antibodies directed against the calretinin antigen. If the antigen is present in the tissue, the antibody binds to it. This binding is subsequently visualized under a high-resolution light microscope using a secondary detection system conjugated with an enzyme (such as horseradish peroxidase) and a chromogen (such as diaminobenzidine), which produces a distinct brown staining pattern in both the cytoplasm and the nucleus of positive cells.

The clinical importance of Calretin Immunohistochemistry cannot be overstated. It is widely recognized as one of the most reliable positive markers for malignant mesothelioma, effectively distinguishing it from metastatic pulmonary adenocarcinoma, which is typically negative for calretinin. Furthermore, in pediatric pathology, this test plays a critical role in the diagnostic workup of Hirschsprung's disease. By evaluating the presence or absence of calretinin-positive nerve fibers in rectal suction biopsies, pathologists can confidently confirm or rule out this congenital condition. The diagnostic value of this test lies in its ability to provide objective, reproducible, and definitive diagnostic criteria, which directly guides oncologists, pediatric surgeons, and pulmonologists in formulating precise treatment strategies for patients in Peshawar and surrounding regions.

Clinical Procedure: What to Expect

Patient Preparation

Because Calretin Immunohistochemistry is performed on tissue specimens that have already been obtained via surgical resection, core needle biopsy, fine-needle aspiration, or endoscopic biopsy, there is no direct patient preparation required for the laboratory staining process itself. However, patients should observe the following guidelines regarding specimen submission and clinical coordination:

• Specimen Submission: Ensure that the Formalin-Fixed Paraffin-Embedded (FFPE) tissue block and the corresponding hematoxylin and eosin (H&E) stained slides are safely transported to Test Zone Diagnostic Center.
• Clinical Documentation: Provide a complete clinical history, including previous pathology reports, surgical notes, imaging findings (such as CT or MRI scans), and the specific clinical question the referring physician wishes to resolve.
• Biopsy Preparation (if applicable): If the biopsy has not yet been performed, follow the specific preparation instructions provided by your surgeon or gastroenterologist, which may include fasting or temporarily discontinuing blood-thinning medications.
• Fixation Requirements: Ensure the tissue specimen was fixed in 10% neutral buffered formalin promptly after surgical removal to preserve antigenicity and prevent tissue autolysis.

During the Procedure

The laboratory workflow for Calretin Immunohistochemistry at Test Zone Diagnostic Center involves several meticulous, quality-controlled steps executed by experienced histotechnologists and evaluated by consultant pathologists:

• Tissue Sectioning: The paraffin block containing the patient's tissue is mounted on a microtome, and ultra-thin sections (approximately 3 to 4 microns thick) are cut and placed onto specialized charged glass slides.
• Deparaffinization and Rehydration: The slides are heated and treated with clearing agents (such as xylene) and graded alcohols to remove the paraffin wax and rehydrate the tissue sections.
• Antigen Retrieval: To expose the calretinin epitopes that may have been masked during formalin fixation, the slides undergo Heat-Induced Epitope Retrieval (HIER) using a buffered solution in a temperature-controlled water bath or pressure cooker.
• Antibody Incubation: The tissue sections are incubated with a primary anti-calretinin antibody under optimized dilution and temperature conditions to ensure specific binding.
• Detection and Visualization: A polymer-based secondary detection system is applied, followed by the addition of a chromogen substrate. This chemical reaction deposits a visible brown precipitate at the site of antigen-antibody binding.
• Counterstaining and Mounting: The slides are counterstained with hematoxylin to visualize cellular nuclei (staining them blue), dehydrated, and sealed with a coverslip for microscopic examination.
• Pathological Evaluation: A consultant pathologist examines the slides under a light microscope, evaluating the intensity, distribution, and localization (cytoplasmic and nuclear) of the staining.

When is a Calretin Immunohistochemistry Performed?

Diagnosing Malignant Mesothelioma

Physicians request Calretin Immunohistochemistry when a patient presents with symptoms such as progressive dyspnea, pleural effusion, and chest wall pain, and imaging studies reveal pleural thickening or a pleural mass. Malignant pleural mesothelioma is a highly aggressive tumor strongly associated with asbestos exposure. Because its histological appearance can closely mimic metastatic adenocarcinoma of the lung, pathologists utilize a panel of immunohistochemical markers. Calretin is highly sensitive and specific for mesothelial cells, showing diffuse, strong cytoplasmic and nuclear positivity in mesothelioma, whereas adenocarcinomas are almost universally negative or show only focal, weak cytoplasmic staining.

Evaluating Hirschsprung's Disease

In pediatric gastroenterology, Calretin Immunohistochemistry is requested for neonates and infants presenting with symptoms of intestinal obstruction, delayed passage of meconium, abdominal distension, and chronic constipation. Hirschsprung's disease is characterized by the congenital absence of ganglion cells in the distal bowel wall. While traditional diagnosis relies on identifying the absence of ganglion cells on H&E staining, this can be extremely challenging in small suction biopsies. Calretin IHC serves as an invaluable diagnostic aid; in a normal bowel, calretinin-positive nerve fibers are abundant in the lamina propria and muscularis mucosae, whereas in Hirschsprung's disease, these positive fibers are completely absent, providing a clear, objective diagnostic threshold.

Identifying Adrenal Cortical Tumors

Endocrinologists and oncologists utilize this test when evaluating patients with retroperitoneal masses or adrenal tumors. Differentiating adrenal cortical neoplasms (such as adrenal cortical adenoma or carcinoma) from other tumors like renal cell carcinoma or pheochromocytoma is clinically vital. Calretinin is consistently expressed in normal and neoplastic adrenal cortical tissue. A positive calretinin stain, combined with other markers like Melan-A and Synaptophysin, helps confirm an adrenal cortical origin, facilitating accurate staging and therapeutic planning.

Assessing Ovarian and Testicular Tumors

Gynecologic oncologists and urologists recommend Calretin Immunohistochemistry when investigating complex pelvic masses or testicular tumors. Calretinin is expressed in specific sex cord-stromal tumors of the ovary and testis, including granulosa cell tumors, Sertoli-Leydig cell tumors, and Leydig cell tumors. It helps differentiate these neoplasms from epithelial ovarian carcinomas or germ cell tumors, which require vastly different surgical and chemotherapeutic protocols.

Investigating Central Nervous System Lesions

Neurologists and neurosurgeons may require Calretin Immunohistochemistry during the evaluation of brain biopsies. Calretinin is physiologically expressed in various populations of interneurons within the cerebral cortex, hippocampus, and cerebellar cortex. In neuro-oncology, it can assist in characterizing specific neuronal and mixed glioneuronal tumors, helping to determine the lineage and differentiation pathway of complex central nervous system lesions.

What Does a Calretin Immunohistochemistry Detect?

Calretin Immunohistochemistry is designed to detect the cellular expression, localization, and distribution of the calretinin protein. The test detects and assists in characterizing the following pathological and physiological states:

• Diffuse nuclear and cytoplasmic staining in epithelioid malignant mesothelioma.
• Absence of nuclear staining in pulmonary adenocarcinoma, confirming a non-mesothelial origin.
• Presence of calretinin-positive ganglion cells in the submucosal (Meissner's) and myenteric (Auerbach's) plexuses of a normal colon.
• Complete absence of calretinin-positive mucosal nerve fibers in the aganglionic segment of patients with Hirschsprung's disease.
• Strong cytoplasmic and nuclear positivity in adrenal cortical adenomas.
• Absence of calretinin expression in renal cell carcinomas metastasizing to the adrenal gland.
• Positivity in ovarian granulosa cell tumors, aiding in their differentiation from endometrioid carcinomas.
• Expression in testicular Leydig cell tumors and Sertoli cell tumors.
• Calretinin immunoreactivity in synovial sarcomas, helping to distinguish them from other spindle cell neoplasms.
• Presence of calretinin in specific cortical interneurons, assisting in neurodevelopmental research and diagnostic neuropathology.
• Focal positivity in certain benign mesothelial hyperplasia cases, helping to assess reactive versus neoplastic mesothelial proliferations.
• Expression in cardiac myxomas, confirming the diagnosis of these benign endocardial tumors.
• Expression in ameloblastomas and other odontogenic tumors.
• Absence of staining in gastrointestinal stromal tumors (GIST), helping to rule out neural crest-derived mimics.
• Staining patterns in mesothelioma variants, including sarcomatoid mesothelioma (which may show reduced or focal positivity).
• Expression in certain types of breast carcinomas, particularly those with medullary features.
• Positivity in specific cutaneous adnexal tumors.
• Staining in reactive pleural plaques to assess the extent of benign asbestos-related tissue changes.
• Presence of calretinin in normal peritoneal mesothelial cells during staging laparoscopy for abdominal malignancies.
• Absence of calretinin in metastatic signet ring cell carcinomas of the gastrointestinal tract.

Turnaround Time and Report Access at Test Zone Diagnostic Center

At Test Zone Diagnostic Center in Peshawar, Pakistan, we understand that timely and accurate diagnostic reports are critical for clinical decision-making, particularly in oncological and pediatric cases. The turnaround time for Calretin Immunohistochemistry typically ranges from 3 to 5 working days. This timeframe is necessary to ensure rigorous quality control, including precise tissue sectioning, antigen retrieval, overnight antibody incubation, and detailed microscopic evaluation by our consultant histopathologists.

Once the pathologist completes the microscopic analysis and signs off on the diagnostic report, patients and referring physicians are notified immediately. Test Zone Diagnostic Center provides multiple convenient ways to access reports. Patients can collect their physical reports directly from our main diagnostic facility in Peshawar. Additionally, reports can be accessed and downloaded securely online through our official patient portal, ensuring that patients and their healthcare providers have immediate access to vital diagnostic data, regardless of their location.

Calretin Immunohistochemistry Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Pleural Tissue	Strong, diffuse cytoplasmic and nuclear staining in normal mesothelial lining.	Diffuse, intense staining in malignant epithelioid mesothelioma; negative or weak focal staining in metastatic adenocarcinoma.
Colorectal Biopsy (Lamina Propria)	Abundant, delicate calretinin-positive nerve fibers present in the lamina propria and muscularis mucosae.	Complete absence of calretinin-positive nerve fibers, strongly indicative of Hirschsprung's disease.
Submucosal Plexus (Colon)	Presence of calretinin-positive ganglion cells.	Absence of ganglion cells and associated positive nerve fibers in aganglionic megacolon.
Adrenal Gland	Moderate to strong staining in the cells of the adrenal cortex.	Strong positivity in adrenal cortical carcinoma; negative staining in metastatic renal cell carcinoma or pheochromocytoma.
Ovarian Tissue	Positivity in the theca and granulosa cells of normal follicles.	Diffuse cytoplasmic and nuclear positivity in granulosa cell tumors; negative in most epithelial ovarian cancers.
Testicular Tissue	Positivity in interstitial Leydig cells.	Strong expression in Leydig cell tumors and Sertoli-Leydig cell tumors.
Synovial Tissue	Negative staining in normal synovial lining cells.	Positivity in synovial sarcoma, assisting in differentiating it from other soft tissue sarcomas.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient's symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Test Zone Diagnostic Center for Calretin Immunohistochemistry?

• Experienced Healthcare Professionals: Our pathology department is led by highly qualified consultant histopathologists with extensive experience in immunohistochemical analysis.
• Patient-Focused Care: We prioritize patient comfort, clear communication, and compassionate service throughout the diagnostic journey.
• Quality Diagnostic Services: Test Zone Diagnostic Center adheres to strict international laboratory standards and rigorous internal and external quality control protocols.
• Professional Reporting: We provide comprehensive, detailed, and clear diagnostic reports that integrate clinical history with advanced staining patterns.
• Modern Diagnostic Approach: Our laboratory utilizes advanced automated IHC staining platforms to ensure consistency, reproducibility, and high staining quality.
• Comfortable Environment: Our state-of-the-art facility in Peshawar offers a clean, professional, and welcoming environment for all patients.
• Convenient Location: Located centrally in Peshawar, Pakistan, our center is easily accessible for patients from across the province.
• Commitment to Accurate Diagnosis: We are dedicated to providing precise, evidence-based diagnostic results that physicians can trust for critical treatment planning.